Julia Q.
- Country
- France
- Department
- Medical oncology
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Breast Oncology
Therapeutic research in hormone‑responsive and HER2‑targeted disease subtypes.
- HR+/HER2‑negative advanced breast cancer
- HER2‑positive metastatic breast cancer
- HER2‑low breast cancer
- Endocrine‑resistant breast cancer
Emphasis on novel antibody‑drug conjugates and resistance pathways.
Lung Cancer
Targeted and immunologic strategies for non‑small cell lung malignancies.
- EGFR‑mutated NSCLC
- ALK‑rearranged NSCLC
- ROS1‑positive NSCLC
- KRAS G12C‑mutant NSCLC
Focus on first‑line combination regimens and biomarker‑driven trials.
Urologic Oncology
Advances in prostate and urothelial malignancies.
- Metastatic castration‑resistant prostate cancer
- High‑risk localized prostate cancer
- Muscle‑invasive bladder cancer
- FGFR3‑altered urothelial carcinoma
Integrates androgen‑axis inhibition, immunotherapy, and targeted agents.
Gastrointestinal Oncology
Precision medicine for colorectal, gastric, and biliary tract tumors.
- Microsatellite‑stable metastatic colorectal cancer
- HER2‑positive gastro‑esophageal adenocarcinoma
- Biliary tract carcinoma with FGFR alterations
- Advanced gastric adenocarcinoma
Explores anti‑angiogenic combinations and molecularly selected cohorts.
Neuro‑Oncology
Clinical focus on high‑grade gliomas and diffuse midline glioma.
- Diffuse intrinsic pontine glioma
- H3K28M‑mutant diffuse midline glioma
- MGMT‑unmethylated glioblastoma
- Brainstem glioma with radiologic progression
Targets epigenetic regulators and radiosensitizing approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.